SAR 216471 hydrochloride
Potent P2Y12 antagonist (IC50 = 17 nM). Displays antiplatelet and antithrombotic activity in vivo. Orally available.
|Storage||Store at -20°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
|Solvent||Max Conc. mg/mL||Max Conc. mM|
|DMSO||11.99||20mM with gentle warming|
Preparing Stock Solutions
The following data is based on the product molecular weight 599.51. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||1.67 mL||8.34 mL||16.68 mL|
|5 mM||0.33 mL||1.67 mL||3.34 mL|
|10 mM||0.17 mL||0.83 mL||1.67 mL|
|50 mM||0.03 mL||0.17 mL||0.33 mL|
The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.
References are publications that support the products' biological activity.
Boldron et al (2014) N-[6-(4-butanoyl-5-methyl-1H-pyrazol-1-yl)pyridazin-3-yl]-5-chloro-1-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-1H-indole-3-carboxamide (SAR216471), a novel intravenous and oral, reversible, and directly acting P2Y12 antagonist. J.Med.Chem. 57 7293 PMID: 25075638
If you know of a relevant reference for SAR 216471 hydrochloride, please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: SAR216471 hydrochloride potent P2Y12 antagonists antiplatelets antithrombotics orally available bioavailable purine receptors purinoceptors purinergic Purinergic P2Y Receptors
Citations for SAR 216471 hydrochloride
Citations are publications that use Tocris products.
Currently there are no citations for SAR 216471 hydrochloride. Do you know of a great paper that uses SAR 216471 hydrochloride from Tocris? If so please let us know.